Sanders, Catherine
Adaptive Biotechnologies (United States)
3 papers on CoChatORCID 0000-0001-5058-0486
Most cited papers
- Verified
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Cloughesy, T. F., Mochizuki, A. Y., Orpilla, J. R., Hugo, W., Lee, A. H., Davidson, T. B., Wang, A. C., Ellingson, B. M., Rytlewski, J. A., Sanders, C. M., et al. (2019) · Nature Medicine
Glioma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 1,382
- Verified
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Lavin, Y., Kobayashi, S., Leader, A., Amir, E.-A. D., Elefant, N., Bigenwald, C., Remark, R., Sweeney, R., Becker, C. D., Levine, J. H., et al. (2017) · Cell
Cancer Immunotherapy and BiomarkersSingle-cell and spatial transcriptomics
Cited by 1,209
- Verified
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Johnson, D. B., Frampton, G. M., Rioth, M. J., Yusko, E., Xu, Y., Guo, X., Ennis, R. C., Fabrizio, D., Chalmers, Z. R., Greenbowe, J., et al. (2016) · Cancer Immunology Research
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 481
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free